Schistosoma mansoni infection alters the host pre-vaccination environment resulting in blunted Hepatitis B vaccination immune responses.


Journal

PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488

Informations de publication

Date de publication:
07 2023
Historique:
received: 10 01 2023
accepted: 20 06 2023
revised: 17 07 2023
medline: 19 7 2023
pubmed: 5 7 2023
entrez: 5 7 2023
Statut: epublish

Résumé

Schistosomiasis is a disease caused by parasitic flatworms of the Schistosoma spp., and is increasingly recognized to alter the immune system, and the potential to respond to vaccines. The impact of endemic infections on protective immunity is critical to inform vaccination strategies globally. We assessed the influence of Schistosoma mansoni worm burden on multiple host vaccine-related immune parameters in a Ugandan fishing cohort (n = 75) given three doses of a Hepatitis B (HepB) vaccine at baseline and multiple timepoints post-vaccination. We observed distinct differences in immune responses in instances of higher worm burden, compared to low worm burden or non-infected. Concentrations of pre-vaccination serum schistosome-specific circulating anodic antigen (CAA), linked to worm burden, showed a significant bimodal distribution associated with HepB titers, which was lower in individuals with higher CAA values at month 7 post-vaccination (M7). Comparative chemokine/cytokine responses revealed significant upregulation of CCL19, CXCL9 and CCL17 known to be involved in T cell activation and recruitment, in higher CAA individuals, and CCL17 correlated negatively with HepB titers at month 12 post-vaccination. We show that HepB-specific CD4+ T cell memory responses correlated positively with HepB titers at M7. We further established that those participants with high CAA had significantly lower frequencies of circulating T follicular helper (cTfh) subpopulations pre- and post-vaccination, but higher regulatory T cells (Tregs) post-vaccination, suggesting changes in the immune microenvironment in high CAA could favor Treg recruitment and activation. Additionally, we found that changes in the levels of innate-related cytokines/chemokines CXCL10, IL-1β, and CCL26, involved in driving T helper responses, were associated with increasing CAA concentration. This study provides further insight on pre-vaccination host responses to Schistosoma worm burden which will support our understanding of vaccine responses altered by pathogenic host immune mechanisms and memory function and explain abrogated vaccine responses in communities with endemic infections.

Identifiants

pubmed: 37406029
doi: 10.1371/journal.pntd.0011089
pii: PNTD-D-23-00046
pmc: PMC10351710
doi:

Substances chimiques

gamma-hydroxy-gamma-ethyl-gamma-phenylbutyramide 67880-30-2
Antigens, Helminth 0
Cytokines 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0011089

Subventions

Organisme : NIAID NIH HHS
ID : U19 AI128910
Pays : United States

Commentaires et corrections

Type : UpdateOf

Informations de copyright

Copyright: © 2023 Muir et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Science. 2021 Dec 03;374(6572):abm0829
pubmed: 34648302
Vaccine. 2006 Apr 5;24(15):2987-93
pubmed: 16500735
Vaccine. 2005 Feb 3;23(11):1326-34
pubmed: 15661380
PLoS Negl Trop Dis. 2016 Dec 7;10(12):e0005180
pubmed: 27926921
Immunity. 2019 May 21;50(5):1132-1148
pubmed: 31117010
PLoS One. 2022 Jan 21;17(1):e0262126
pubmed: 35061771
Immunity. 2011 Jan 28;34(1):108-21
pubmed: 21215658
Clin Immunol. 2020 Sep;218:108515
pubmed: 32619646
Sci Rep. 2016 May 27;6:26494
pubmed: 27231124
Postgrad Med J. 1987;63 Suppl 2:169-77
pubmed: 3317357
PLoS Pathog. 2021 Mar 15;17(3):e1009363
pubmed: 33720973
PLoS One. 2012;7(11):e48727
pubmed: 23144947
Int J Parasitol. 2006 Oct;36(12):1241-4
pubmed: 16930605
Clin Microbiol Rev. 2019 Mar 13;32(2):
pubmed: 30867162
Hepat Med. 2019 Sep 03;11:131-136
pubmed: 31565002
Nature. 2021 Jul 1;:
pubmed: 34211170
PLoS Pathog. 2021 May 20;17(5):e1009555
pubmed: 34015063
Cell Rep. 2021 Aug 10;36(6):109504
pubmed: 34352226
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2005 Jun 30;23(3):163-5
pubmed: 16300009
PLoS Pathog. 2022 Feb 14;18(2):e1010327
pubmed: 35157732
J Parasitol. 1996 Aug;82(4):557-64
pubmed: 8691363
Parasit Vectors. 2015 Apr 22;8:241
pubmed: 25896512
PLoS Pathog. 2016 Jul 27;12(7):e1005777
pubmed: 27463374
Am J Trop Med Hyg. 2020 Jul;103(1_Suppl):50-57
pubmed: 32400344
Parasitology. 2014 Dec;141(14):1841-55
pubmed: 24932595
Pathogens. 2021 Jul 08;10(7):
pubmed: 34358013
Front Immunol. 2021 Dec 10;12:748387
pubmed: 34956183
Int Immunol. 1999 Jan;11(1):81-8
pubmed: 10050676
J Clin Microbiol. 2008 Jan;46(1):171-6
pubmed: 17942645
Annu Rev Immunol. 2016 May 20;34:335-68
pubmed: 26907215
J Immunol. 2015 Dec 15;195(12):5625-36
pubmed: 26546609
Parasite Immunol. 2005 Oct-Nov;27(10-11):385-93
pubmed: 16179032
IEE Proc Nanobiotechnol. 2005 Apr;152(2):64-72
pubmed: 16441160
Lancet. 2014 May 17;383(9930):1707-8
pubmed: 24843875
Front Immunol. 2020 Jun 09;11:1018
pubmed: 32582161
Immunol Rev. 2018 Jan;281(1):8-27
pubmed: 29247995
BMC Public Health. 2021 Feb 23;21(1):394
pubmed: 33622281
Nat Immunol. 2022 Dec;23(12):1777-1787
pubmed: 36316476
Int J Cancer. 2008 May 15;122(10):2286-93
pubmed: 18224687
Sex Transm Infect. 2011 Oct;87(6):511-5
pubmed: 21835763
Infect Dis Poverty. 2017 Nov 1;6(1):155
pubmed: 29089064
BMJ Open. 2021 Feb 16;11(2):e040426
pubmed: 33593768
Int J Mol Sci. 2021 Jul 05;22(13):
pubmed: 34281269
Front Immunol. 2018 Aug 15;9:1884
pubmed: 30158933
BMJ. 2011 May 17;342:d2651
pubmed: 21586478
World J Hepatol. 2015 Oct 28;7(24):2503-9
pubmed: 26523203
Trends Parasitol. 2022 Jan;38(1):67-79
pubmed: 34389214
BMJ Open. 2021 Feb 16;11(2):e040425
pubmed: 33593767
Front Immunol. 2018 Apr 25;9:883
pubmed: 29887862
Trends Immunol. 2021 Jun;42(6):536-550
pubmed: 33972167
Clin Transl Immunology. 2020 May 13;9(5):e1129
pubmed: 32419947
Cell Rep. 2017 Aug 29;20(9):2251-2261
pubmed: 28854372
PLoS Negl Trop Dis. 2021 Oct 27;15(10):e0009893
pubmed: 34705819
Eur J Immunol. 1999 Sep;29(9):2684-94
pubmed: 10508243
Front Immunol. 2020 Feb 18;11:61
pubmed: 32132991
Front Immunol. 2018 Nov 28;9:2781
pubmed: 30546364
Int J Biol Sci. 2015 Jul 15;11(9):1049-55
pubmed: 26221072
Nat Rev Immunol. 2021 Feb;21(2):83-100
pubmed: 33353987
Nat Rev Immunol. 2021 Aug;21(8):475-484
pubmed: 34211186
PLoS Pathog. 2018 Jul 26;14(7):e1007182
pubmed: 30048550
Aging Cell. 2015 Jun;14(3):421-32
pubmed: 25728020
J Immunol Methods. 2012 Dec 14;386(1-2):117-23
pubmed: 23023091
J Immunol. 2010 Dec 1;185(11):6472-9
pubmed: 20974991
J Clin Invest. 2019 Mar 7;129(5):1960-1971
pubmed: 30843873
Front Immunol. 2021 Mar 04;12:635985
pubmed: 33746974
Nat Immunol. 2016 Oct;17(10):1226-34
pubmed: 27525369
Mol Med. 2021 Apr 1;27(1):32
pubmed: 33794763
Front Immunol. 2013 Feb 20;4:39
pubmed: 23429492
Afr Health Sci. 2009 Jun;9(2):98-108
pubmed: 19652743
Parasit Vectors. 2016 Jun 06;9(1):321
pubmed: 27266984

Auteurs

Roshell Muir (R)

Division of Infectious Diseases and HIV Medicine, Department of Medicine, Drexel University College of Medicine, Philadelphia, Pennsylvania, United States of America.

Talibah Metcalf (T)

Division of Infectious Diseases and HIV Medicine, Department of Medicine, Drexel University College of Medicine, Philadelphia, Pennsylvania, United States of America.

Slim Fourati (S)

PATRU, School of Medicine, Emory University, Atlanta, Georgia, United States of America.

Yannic Bartsch (Y)

Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, United States of America.

Jacqueline Kyosiimire-Lugemwa (J)

MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda.

Glenda Canderan (G)

Department of Medicine, Allergy and Immunology, University of Virginia, Charlottesville, Virginia, United States of America.

Galit Alter (G)

Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, United States of America.

Enoch Muyanja (E)

PATRU, School of Medicine, Emory University, Atlanta, Georgia, United States of America.
UVRI-IAVI HIV Vaccine Program, Entebbe, Uganda.

Brenda Okech (B)

UVRI-IAVI HIV Vaccine Program, Entebbe, Uganda.

Teddy Namatovu (T)

UVRI-IAVI HIV Vaccine Program, Entebbe, Uganda.

Irene Namara (I)

UVRI-IAVI HIV Vaccine Program, Entebbe, Uganda.

Annemarie Namuniina (A)

UVRI-IAVI HIV Vaccine Program, Entebbe, Uganda.

Ali Ssetaala (A)

UVRI-IAVI HIV Vaccine Program, Entebbe, Uganda.

Juliet Mpendo (J)

UVRI-IAVI HIV Vaccine Program, Entebbe, Uganda.

Annet Nanvubya (A)

UVRI-IAVI HIV Vaccine Program, Entebbe, Uganda.

Paul Kato Kitandwe (PK)

MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda.

Bernard S Bagaya (BS)

Department of Immunology and Molecular Biology, School of Biomedical Sciences, Makerere University, College of Health Sciences, Kampala, Uganda.

Noah Kiwanuka (N)

Department of Epidemiology and Biostatistics, School of Public Health, Makerere University, College of Health Sciences, Kampala, Uganda.

Jacent Nassuna (J)

Department of Epidemiology and Biostatistics, School of Public Health, Makerere University, College of Health Sciences, Kampala, Uganda.

Victoria Menya Biribawa (VM)

UVRI-IAVI HIV Vaccine Program, Entebbe, Uganda.

Alison M Elliott (AM)

MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda.
Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, United Kingdom.

Claudia J de Dood (CJ)

Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, Netherlands.

William Senyonga (W)

MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda.

Priscilla Balungi (P)

MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda.

Pontiano Kaleebu (P)

MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda.

Yunia Mayanja (Y)

MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda.

Matthew Odongo (M)

MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda.

Jennifer Connors (J)

Division of Infectious Diseases and HIV Medicine, Department of Medicine, Drexel University College of Medicine, Philadelphia, Pennsylvania, United States of America.

Pat Fast (P)

International AIDS Vaccine Initiative, New York, New York, United States of America.
Pediatric Infectious Diseases, Stanford University School of Medicine, Palo Alto, California, United States of America.

Matt A Price (MA)

International AIDS Vaccine Initiative, New York, New York, United States of America.
Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, California, United States of America.

Paul L A M Corstjens (PLAM)

Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, Netherlands.

Govert J van Dam (GJ)

Department of Parasitology, Leiden University Medical Center, Leiden, the Netherlands.

Anatoli Kamali (A)

UVRI-IAVI HIV Vaccine Program, Entebbe, Uganda.
International AIDS Vaccine Initiative, New York, New York, United States of America.
IAVI, New York, New York, United States of America, and Nairobi, Kenya.

Rafick Pierre Sekaly (RP)

PATRU, School of Medicine, Emory University, Atlanta, Georgia, United States of America.

Elias K Haddad (EK)

Division of Infectious Diseases and HIV Medicine, Department of Medicine, Drexel University College of Medicine, Philadelphia, Pennsylvania, United States of America.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH